A new approach to estimate Genital Warts incidence and prevalence in the Italian general female population

Italian Journal of Gynaecology and Obstetrics

Volumn 20, Issue 1, 2008, Pages 33-42

  Vittori, G ^a   Matteelli, A ^b   Boselli, F ^c   Naldi, L ^d   Gialloreti, L Emberti ^e  

^a SAN CARLO DI NANCY HOSPITAL   (Italy)

^b SPEDALI CIVILI   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d GISED   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Genital warts; Human papillomavirus; Incidence; Prevalence; Quadrivalent vaccine

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONDYLOMA ACUMINATUM; EVIDENCE BASED PRACTICE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HUMAN; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; POPULATION RESEARCH; PREVALENCE; RECURRENT INFECTION; RETROSPECTIVE STUDY; VACCINATION; WART VIRUS; WOMEN'S HEALTH;

EID: 44949191262     PISSN: 11218339     EISSN: 23850868     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Koutski LA. Epidemiology of genital human papillomavirus infection. 1997;102(5A):3-8.
2. Bernard HU. The clinical importance of nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol 2005;32(Suppl 1):S1-6.
3. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide. A meta analysis. Br J Cancer 2003;88(1):63-73.
4. von Krogh G. Management of anogenital warts (condylomata acuminata). Eur J Dermatol 2001;11:598-603.
5. CDC, Sexually Transmitted Disease Guidelines. MMWR, 4 Aug 2006;55:R11.
6. Kodner CM, Nasraty S. Management of genital warts. Am Fam Physician. 2004;70(12):2335-42.
7. Insinga RP, Dasbach EJ, Myers ER. The health and economic burden of genital warts in a set of private health plans in the United States. Chin Infect Dis. 2003;36(11):1397-403.
8. French L, Nashelsky J. Clinical inquiries. What is the most effective treatment for external genital warts? J Fam Pract. 2002;51(4):313.
9. Maw RD, Reitano M, Roy M. An observational survey of patients with genital warts: perception regarding treatment and impact on lifestyle. Int J STD AIDS. 1998;9(10):571-8.
10. Voog E, Löwhagen GB. Follow-up of men with genital papilloma virus infection. Psychosexual aspects. Acta Derm Venereol. 1992;72(3): 185-6.
11. Filiberti A, Tamburini M, Stefanon B, Merola M, Bandieramonte G, Ventafridda V, et al. Psychological aspects of genital human papillomavirus infection: a preliminary report. J Psychosom Obstet Gynaecol. 1993;14(2):145-52.
12. Giuliani M, et al. Il controllo delle malattie a trasmissione sessuale. G Italiano Dermatol Venereol, 1991;126:411-17.
13. Gilson RJ, Mindel A. Recent advances: Sexually transmitted infections. BMJ. 2001; 322(7295): 1160-4.
14. Giuliani M, Suligoi B. The STD Surveillance Working Group, Sentinel Surveillance of sexually transmitted diseases in Italy. Eurosurveillance, 1998;3:55-58.
15. ISTAT, Indagine Multiscopo 2005.
16. Fallani MG, Penna C, Gordigiani R, Sonni L, Maggiorelli M, Marchionni M. Human papillomavirus infections in the lower genital tract of women. Minerva Ginecol. 1993;45(4):149-58.
17. Hardin J, Hilbe J. Generalized linear models and extension. Stata Press College Station 2001.
18. PHLS. CDR Weekly 2001;11(35).
19. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ, Vaccarella S, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005; 366(9490):991-8.
20. Monsonégo J, Breugelmans JG, Bouée S, Lafuma A, Bénard S, Rémy V. Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France. Gynecol Obstet Fertil. 2007;35(2):107-13.
21. Kyriakis KP, Hadjivassiliou M, Paparizos VA, Riga P, Katsambas A. Determinants of GW cases detection rates among STD clinics in Atheens, Greece. Int J Dermatol 2005;44:650-3.
22. Brown RE, Breugelmans JG, Theodoratou D, Bénard S. Cost of detection and treatment of cervical cancer, cervical dysplasia and genital warts in UK. Curr Med Res Opin 2006; 22:663-70.
23. Kjaer SK, Tran TN, Sparen P, Tryggvadottir L, Munk C, Dasbach E, Liaw KL, Nygård J, Nygård M. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis. 2007;196(10):1447-54.
24. Health Protection Agency, HIV and other Sexually Transmitted Infections in the United Kingdom in 2003 Annual Report, November 2004.
25. Health Protection Agency, A Complex Picture - HIV and other Sexually Transmitted Infections in the United Kingdom: 2006.
26. Persson G, Andersson K, Krantz I. Symptomatic genital papillomavirus infection in a community. Incidence and clinical picture. Acta Obstet Gynecol Scand. 1996;75(3):287-90.
27. Munk C, Svare EI, Poll P, Bock JE, Kjaer SK. History of genital warts in 10,838 women 20 to 29 years of age from the general population. Risk factors and association with papanicolau smear history. Sex Transm Dis. 1997;24(10):567-72.
28. Orduña Domingo A, Chu JJ, Eiros Bouza JM, Bratos Pérez MA, Gutiérrez Rodríguez MP, Almaraz Gómez A, et al. Age and sex distribution of sexually transmitted diseases in Valladolid. A study of 5076 cases. Rev Sanid Hig Publica (Madr). 1991;65(3):247-58.